Canine longevity drug advances toward FDA approvalMarch 4, 2025The FDA’s Center for Veterinary Medicine has accepted the Reasonable Expectation of Effectiveness (RXE) for LOY-002. Learn more about what this ‘milestone’ means in the pursuit of an FDA conditional approval.
SPONSORED CONTENTHow can you help new pet owners keep their new dogs protected?See why new dog owners and their pets can benefit from simple triple protection in one monthly chew. + See the Difference
$45M additional funding bolsters development of canine longevity drugMarch 25, 2024The latest financing round brings the total funds raised for the first FDA-approved dog lifespan extension drug to $125M
